Aurora, CO17 Active Studies

Interstitial Lung Disease Clinical Trials in Aurora, CO

Find 17 actively recruiting interstitial lung disease clinical trials in Aurora, CO. Connect with local research sites and explore new treatment options.

17
Active Trials
9
Sponsors
10,235
Enrolling

Recruiting Interstitial Lung Disease Studies in Aurora

About Interstitial Lung Disease Clinical Trials in Aurora

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 17 interstitial lung disease clinical trials recruiting participants in Aurora, CO. These studies are seeking a combined 10,235 participants. Research is being sponsored by George Washington University, Duke University, University of Colorado, Denver and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Aurora — FAQ

Are there interstitial lung disease clinical trials in Aurora?

Yes, there are 17 interstitial lung disease clinical trials currently recruiting in Aurora, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Aurora?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.

Are clinical trials in Aurora free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 17 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated July 13, 2026 from ClinicalTrials.gov